CASPER VAN DER VEN MSC

PhD Candidate

Calcific Aortic Valve Disease | 3D Bioprinting | Drug Delivery

Using 3D bioprinting, we have engineered the first human calcific aortic valve disease model. This model is now used to study heart valve disease (development), identify therapeutic targets, test drug delivery platforms, and validate novel therapeutics.

Publications:

https://www.ncbi.nlm.nih.gov/pubmed/28057890

https://www.ncbi.nlm.nih.gov/pubmed/29751516

https://www.ncbi.nlm.nih.gov/pubmed/31603288

https://www.springer.com/gp/book/9789811516702

 

©2019 by experimentalcardiologylab. Proudly created with Wix.com. All rights reserved